Forget Zepbound: Lilly's Next Stock Signal for Investors
Lilly’s Zepbound has shaken up the obesity-drug market, but the real upside could come from its next-generation candi...
No fee travel points cards often provide unique perks. Discover how these benefits can maximize your travel rewards.
19,690 articlesLilly’s Zepbound has shaken up the obesity-drug market, but the real upside could come from its next-generation candi...
As fashion rental goes mainstream, rent runway (rent) 2026 will hinge on unit economics, subscriber growth, and susta...
As DocuSign navigates a changing digital transaction landscape, the docusign (DOCU) 2027 earnings thesis hinges on re...
A sharp May rally pushed Planet Labs stock higher on renewed growth expectations and a favorable data-demand backdrop...
A surprise move from Berkshire Hathaway signals a broader embrace of technology bets. This article explains why Alpha...
A growing clash over baseball economics enters a new phase as Trump signals support for a hard salary cap in MLB, int...
A software engineer stands on the cusp of a potential million tax-free gain startup under QSBS rules, but a five-year...
Three Dow components traditionally labeled as old economy stocks have surged past the broader market, driven by durab...
Schg’s 32× start melt-up is shaping a pivotal market moment: can a growth-heavy ETF sustain gains on high valuations,...
The iShares Semiconductor ETF faces a pivotal year as AI-capex decisions by five hyperscalers set the pace. SOXX’s ne...
XRP faces a pivotal week after slipping to the $1 level as sellers test support. This week’s ripple (xrp) price predi...
Imagine a world where SpaceX launches an IPO in July. This article breaks down how a price target could form, the big...